Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Crohn Disease drug therapy"" wg kryterium: Temat


Tytuł :
ALIGNed on adherence: subanalysis of adherence in immune-mediated inflammatory diseases in the DACH region of the global ALIGN study.
Autorzy :
Kolios, A.G.A.
Mrowietz, U.
Hueber, A.J.
Michetti, P.
Mustak‐Blagusz, M.
Sator, P.‐G.
Reinshagen, M.
Wilsmann‐Theis, D.
Gomis‐Kleindienst, S.
Luckey, U.
Rössler, A.
Schiefke, I.
Pokaż więcej
Temat :
Original Article
Clinic for Immunology
Education
610 Medicine & health
Adult
Age Factors
Aged
Aged, 80 and over
Antirheumatic Agents/therapeutic use
Arthritis/drug therapy
Arthritis, Psoriatic/drug therapy
Arthritis, Rheumatoid/drug therapy
Austria
Colitis, Ulcerative/drug therapy
Crohn Disease/drug therapy
Cross-Sectional Studies
Dermatologic Agents/therapeutic use
Female
Gastrointestinal Agents/therapeutic use
Germany
Health Knowledge, Attitudes, Practice
Humans
Male
Medication Adherence/psychology
Middle Aged
Sex Factors
Spondylitis, Ankylosing/drug therapy
Surveys and Questionnaires
Switzerland
Tumor Necrosis Factor-alpha/antagonists & inhibitors
Young Adult
Infectious Diseases, Dermatology
Źródło :
Journal of the European Academy of Dermatology and Venereology
Journal of the European Academy of Dermatology and Venereology, vol. 33, no. 1, pp. 234-241
Kolios, A G A; Hueber, A J; Michetti, P; Mrowietz, U; Mustak-Blagusz, M; Sator, P-G; Reinshagen, M; Wilsmann-Theis, D; Gomis-Kleindienst, S; Luckey, U; Rössler, A; Schiefke, I (2019). ALIGNed on adherence: subanalysis of adherence in immune-mediated inflammatory diseases in the DACH region of the global ALIGN study. Journal of the European Academy of Dermatology and Venerology, 33(1):234-241.
Opis pliku :
application/pdf
Tytuł :
Clinical Predictors of Future Nonadherence in Inflammatory Bowel Disease.
Autorzy :
Severs, Mirjam
Mangen, Marie-Josée J.
Fidder, Herma H.
van der Valk, Mirthe E.
van der Have, Mike
van Bodegraven, Ad A.
Clemens, Cees H. M.
Dijkstra, Gerard
Jansen, Jeroen M.
de Jong, Dirk J.
Mahmmod, Nofel
van de Meeberg, Paul C.
van der Meulen-de Jong, Andrea E.
Pierik, Marieke
Ponsioen, Cyriel Y.
Romberg-Camps, Marielle J. L.
Siersema, Peter D.
Jharap, Bindia
van der Woude, Janneke C.
Zuithoff, Nicolaas P. A.
Oldenburg, Bas
Pokaż więcej
Temat :
Symptom Flare Up
Gastrointestinal Agents/therapeutic use
medication adherence
Odds Ratio
Research Support, Non-U.S. Gov't
Area Under Curve
OUTCOMES
ulcerative colitis
Female
Crohn Disease/drug therapy
MODELS
Risk Factors
ANTI-TNF THERAPY
Gastroenterology
ILLNESS PERCEPTIONS
Middle Aged
QUIESCENT ULCERATIVE-COLITIS
CROHNS-DISEASE
Colitis, Ulcerative/drug therapy
Health Surveys
MANAGEMENT
Severity of Illness Index
Prospective Studies
prediction
Medication Adherence/psychology
Immunology and Allergy
Multicenter Study
Journal Article
Adult
ROC Curve
Humans
Male
Crohn's disease
Age of Onset
Anxiety/psychology
Depression/psychology
Źródło :
Inflammatory bowel diseases, 23(9), 1568 - 1576. John Wiley and Sons Inc.
Inflammatory bowel diseases, 23(9), 1568. John Wiley and Sons Inc.
Inflammatory Bowel Diseases, 23, 1568 - 1576
Inflammatory Bowel Diseases, 23(9), 1568 - 1576. John Wiley and Sons Inc.
Inflammatory Bowel Diseases, 23(9), 1568 - 1576. LIPPINCOTT WILLIAMS & WILKINS
Opis pliku :
image/pdf
Tytuł :
Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation and anti-TNF Treatment.
Autorzy :
Greuter, T.
Bertoldo, F.
Rechner, R.
Straumann, A.
Biedermann, L.
Zeitz, J.
Misselwitz, B.
Scharl, M.
Rogler, G.
Safroneeva, E.
Ali, RAR
Braegger, C.
Heyland, K.
Mueller, P.
Nydegger, A.
Petit, L.M.
Schibli, S.
Furlano, R.I.
Spalinger, J.
Schäppi, M.
Zamora, S.
Froehlich, F.
Herzog, D.
Schoepfer, A.M.
Vavricka, S.R.
Pokaż więcej
Temat :
610 Medicine & health
Adolescent
Anti-Inflammatory Agents/therapeutic use
Child
Child, Preschool
Cholangitis, Sclerosing/diagnosis
Cholangitis, Sclerosing/drug therapy
Cholangitis, Sclerosing/epidemiology
Cholangitis, Sclerosing/etiology
Colitis, Ulcerative/complications
Colitis, Ulcerative/diagnosis
Colitis, Ulcerative/drug therapy
Crohn Disease/complications
Crohn Disease/diagnosis
Crohn Disease/drug therapy
Female
Follow-Up Studies
Humans
Infant
Infant, Newborn
Joint Diseases/diagnosis
Joint Diseases/drug therapy
Joint Diseases/epidemiology
Joint Diseases/etiology
Logistic Models
Male
Prevalence
Retrospective Studies
Skin Diseases/diagnosis
Skin Diseases/drug therapy
Skin Diseases/epidemiology
Skin Diseases/etiology
Tumor Necrosis Factor-alpha/antagonists & inhibitors
Uveitis/diagnosis
Uveitis/drug therapy
Uveitis/epidemiology
Uveitis/etiology
360 Social problems & social services
digestive system diseases
Źródło :
Greuter, Thomas; Bertoldo, Fabio; Rechner, Roman; Straumann, Alex; Biedermann, Luc; Zeitz, Jonas; Misselwitz, Benjamin; Scharl, Michael; Rogler, Gerhard; Safroneeva, Ekaterina; Ali, Raja A; Braegger, Christian; Heyland, Klaas; Mueller, Pascal; Nydegger, Andreas; Petit, Laetitia-Marie; Schibli, Susanne; Furlano, Raoul I; Spalinger, Johannes; Schäppi, Michela; ... (2017). Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation and anti-TNF Treatment. Journal of pediatric gastroenterology and nutrition, 65(2), pp. 200-206. Lippincott Williams & Wilkins 10.1097/MPG.0000000000001455
Journal of pediatric gastroenterology and nutrition, vol. 65, no. 2, pp. 200-206
Opis pliku :
application/pdf
Tytuł :
Evaluation of the efficacy of octreotide LAR in the treatment of Crohn's disease associated refractory diarrhea.
Autorzy :
Martelli, Laura
Colard, Arnaud
Fontaine, Fernand
Deflandre, Jacques
Bastens, Boris
Louis, Edouard
Pokaż więcej
Temat :
Adult
Belgium
Crohn Disease/drug therapy
Diarrhea/drug therapy
Feces
Female
Gastrointestinal Agents/administration & dosage
Humans
Injections, Subcutaneous
Male
Middle Aged
Octreotide/administration & dosage
Treatment Outcome
Crohn's disease
Sandostatin(R) LAR
octreotide
open-label study
refractory diarrhea
Gastroenterology & hepatology [Human health sciences]
Gastroentérologie & hépatologie [Sciences de la santé humaine]
Źródło :
Evaluation of the efficacy of octreotide LAR in the treatment of Crohn's disease associated refractory diarrhea. Scandinavian Journal of Gastroenterology, 52(5), 564-569., United Kingdom. (2017).
Tytuł :
Inadvertent yellow fever vaccination of a patient with Crohn's disease treated with infliximab and methotrexate
Autorzy :
Ekenberg, C.
Friis-Møller, N.
Ulstrup, Thomas
Aalykke, C.
Pokaż więcej
Temat :
Contraindications
Crohn Disease/drug therapy
Female
Humans
Immunosuppressive Agents/therapeutic use
Infliximab/therapeutic use
Medical Errors
Methotrexate/therapeutic use
Middle Aged
Prognosis
Vaccination/adverse effects
Viremia/diagnosis
Yellow Fever/diagnosis
Źródło :
Ekenberg, C, Friis-Møller, N, Ulstrup, T & Aalykke, C 2016, ' Inadvertent yellow fever vaccination of a patient with Crohn's disease treated with infliximab and methotrexate ', BMJ Case Reports, vol. 2016, 215403 . https://doi.org/10.1136/bcr-2016-215403
Tytuł :
Closure of enterovesical fistula in Crohn’s disease with infliximab: case report
Autorzy :
Flávio Steinwurz
Pokaż więcej
Temat :
Crohn disease/drug therapy
Bladder fistula/drug therapy
Antibodies
monoclonal/therapeutic use
Medicine
Źródło :
Einstein (São Paulo), Vol 1, Iss 1, Pp 22-23 (2003)
Opis pliku :
electronic resource
Relacje :
http://www.einstein.br/biblioteca/pdf/Artigo%206.pdf; https://doaj.org/toc/1679-4508
Dostęp URL :
https://doaj.org/article/32b13ba66fa74fb98a8d9363aa6c90ab
Czasopismo naukowe
Tytuł :
Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn’s Disease Patients Failing Infliximab
Autorzy :
Steenholdt, Casper
Brynskov, Jørn
Thomsen, Ole
Munck, Lars K.
Fallingborg, Jan
Christensen, Lisbet A.
Pedersen, Gitte
Kjeldsen, Jens
Jacobsen, Bent A.
Oxholm, Anne Sophie
Kjellberg, Jakob
Bendtzen, Klaus
Ainsworth, Mark A.
Pokaż więcej
Temat :
Anti-infliximab antibody
Crohn’s disease
Inflammatory bowel disease
Infliximab
Loss of response
Maintenance therapy
Single-Blind Method
Follow-Up Studies
Humans
Middle Aged
Male
Young Adult
Anti-Inflammatory Agents, Non-Steroidal/administration & dosage
Time Factors
Treatment Failure
Aged, 80 and over
Adult
Female
Antibodies, Monoclonal/administration & dosage
Crohn Disease/drug therapy
Health Care Costs
Algorithms
Precision Medicine/economics
Cost-Benefit Analysis
Intention to Treat Analysis
Aged
Źródło :
Steenholdt, C, Brynskov, J, Thomsen, O, Munck, L K, Fallingborg, J, Christensen, L A, Pedersen, G, Kjeldsen, J, Jacobsen, B A, Oxholm, A S, Kjellberg, J, Bendtzen, K & Ainsworth, M A 2015, ' Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn’s Disease Patients Failing Infliximab ', Digestive Diseases and Sciences, vol. 60, no. 9, pp. 2762-2770 . https://doi.org/10.1007/s10620-015-3581-4
Tytuł :
Pre-operative use of anti-TNF-alpha agents and the risk of post-operative complications in patients with Crohn's disease--a nationwide cohort study
Autorzy :
Nørgård, Bente Mertz
Nielsen, J.
Qvist, N.
Gradel, K. O.
Schaffalitzky de Muckadell, Ove B.
Kjeldsen, J.
Pokaż więcej
Temat :
Adolescent Adult Aged Aged, 80 and over Anti-Inflammatory Agents/therapeutic use Antibodies, Monoclonal/therapeutic use *Antibodies, Monoclonal, Humanized/therapeutic use Cohort Studies Crohn Disease/drug therapy/*surgery Denmark Female Humans Immunoglobulin Fab Fragments/therapeutic use Logistic Models Male Middle Aged Polyethylene Glycols/therapeutic use *Postoperative Complications Preoperative Care Risk Factors Time Factors Tumor Necrosis Factor-alpha/*antagonists & inhibitors Young Adult
Źródło :
Nørgård, B M, Nielsen, J, Qvist, N, Gradel, K O, Schaffalitzky de Muckadell, O B & Kjeldsen, J 2013, ' Pre-operative use of anti-TNF-alpha agents and the risk of post-operative complications in patients with Crohn's disease--a nationwide cohort study ', Alimentary Pharmacology and Therapeutics, vol. 37, no. 2, pp. 214-224 . https://doi.org/10.1111/apt.12159
Tytuł :
Quinze ans d'anti-TNF dans la maladie de Crohn: comment tirer le meilleur de cette revolution therapeutique?
Fifteen years of use of anti-TNF antibodies in moderate to severe Crohn's disease: how to make the best of this experience
Autorzy :
Louis, Edouard
REENAERS, Catherine
Meuwis, Marie-Alice
VAN KEMSEKE, Catherine
LATOUR, Pascale
CHAPELIER, Nathalie
WERTZ, Sylvie
COIMBRA MARQUES, Carla
MEUNIER, Paul
Belaiche, Jacques
Pokaż więcej
Temat :
Antibodies, Monoclonal/therapeutic use
Crohn Disease/drug therapy
Gastrointestinal Agents/therapeutic use
Humans
Severity of Illness Index
Tumor Necrosis Factor-alpha/antagonists & inhibitors
Gastroenterology & hepatology [Human health sciences]
Gastroentérologie & hépatologie [Sciences de la santé humaine]
Źródło :
Quinze ans d'anti-TNF dans la maladie de Crohn: comment tirer le meilleur de cette revolution therapeutique? Revue Médicale de Liège, 67 Spec No, 8-13., Belgium. (2012).
Tytuł :
A pauci-symptomatic case of documented Hantavirus (Puumala) infection in a patient under anti-TNF treatment.
Autorzy :
Moutschen, Pierre
Bourhaba, Maryam
FRIPPIAT, Frédéric
GIOT, Jean-Baptiste
MEURIS, Christelle
Leonard, Philippe
Moutschen, Michel
Pokaż więcej
Temat :
Adolescent
Antibodies, Viral/blood
Crohn Disease/drug therapy
Hantavirus/immunology
Hantavirus Infections/diagnosis/pathology
Humans
Immunologic Factors/therapeutic use
Male
Serologic Tests
Tumor Necrosis Factor-alpha/antagonists & inhibitors
General & internal medicine [Human health sciences]
Médecine générale & interne [Sciences de la santé humaine]
Źródło :
A pauci-symptomatic case of documented Hantavirus (Puumala) infection in a patient under anti-TNF treatment. Journal of Clinical Virology, 50(3), 247-8.Amsterdam, The NetherlandsElsevier Science. (2011).

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies